Regeneron Pharmaceuticals Stock (NASDAQ: REGN) stock price, news, charts, stock research, profile.
Open | $970.380 |
Close | $962.490 |
Volume / Avg. | 461.867K / 517.809K |
Day Range | 959.250 - 970.790 |
52 Wk Range | 684.805 - 998.325 |
Market Cap | $105.645B |
P/E Ratio | 27.808 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 1.48% |
Days to Cover | 2.63 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Regeneron Pharmaceuticals (NASDAQ: REGN) through any online brokerage.
Other companies in Regeneron Pharmaceuticals’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
The latest price target for Regeneron Pharmaceuticals (NASDAQ: REGN) was reported by Truist Securities on Tuesday, March 26, 2024. The analyst firm set a price target for 1135.00 expecting REGN to rise to within 12 months (a possible 17.92% upside). 62 analyst firms have reported ratings in the last year.
The stock price for Regeneron Pharmaceuticals (NASDAQ: REGN) is $962.49 last updated March 28, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Regeneron Pharmaceuticals.
Regeneron Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Regeneron Pharmaceuticals.
Regeneron Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.